[HTML][HTML] Real-world survival outcomes based on EGFR mutation status in Chinese patients with lung adenocarcinoma after complete resection: results from the ICAN …
XN Yang, HH Yan, J Wang, XY Chu, ZD Liu… - JTO clinical and …, 2022 - Elsevier
Introduction The adjuvant treatment of patients with resected lung adenocarcinoma (LUAD)
remains unstandardized. We analyzed the survival outcomes of these patients based on …
remains unstandardized. We analyzed the survival outcomes of these patients based on …
[HTML][HTML] Real-World Survival Outcomes Based on EGFR Mutation Status in Chinese Patients With Lung Adenocarcinoma After Complete Resection: Results From the …
XN Yang, HH Yan, J Wang, XY Chu… - JTO Clinical and …, 2022 - ncbi.nlm.nih.gov
Methods This noninterventional real-world study (ICAN) enrolled Chinese patients with
resected stages I to III LUAD from April 8, 2010, to December 31, 2010. Tumor EGFR …
resected stages I to III LUAD from April 8, 2010, to December 31, 2010. Tumor EGFR …
Real-World Survival Outcomes Based on EGFR Mutation Status in Chinese Patients With Lung Adenocarcinoma After Complete Resection: Results From the ICAN …
XN Yang, HH Yan, J Wang, XY Chu… - JTO clinical and …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction The adjuvant treatment of patients with resected lung adenocarcinoma (LUAD)
remains unstandardized. We analyzed the survival outcomes of these patients based on …
remains unstandardized. We analyzed the survival outcomes of these patients based on …
[HTML][HTML] Real-World Survival Outcomes Based on EGFR Mutation Status in Chinese Patients With Lung Adenocarcinoma After Complete Resection: Results From the …
XN Yang, HH Yan, J Wang, XY Chu, ZD Liu… - JTO Clinical and …, 2022 - jtocrr.org
Introduction The adjuvant treatment of patients with resected lung adenocarcinoma (LUAD)
remains unstandardized. We analyzed the survival outcomes of these patients based on …
remains unstandardized. We analyzed the survival outcomes of these patients based on …
Real-World Survival Outcomes Based on EGFR Mutation Status in Chinese Patients With Lung Adenocarcinoma After Complete Resection: Results From the ICAN …
XN Yang, HH Yan, J Wang, XY Chu, ZD Liu… - JTO Clinical and …, 2021 - europepmc.org
Methods This noninterventional real-world study (ICAN) enrolled Chinese patients with
resected stages I to III LUAD from April 8, 2010, to December 31, 2010. Tumor EGFR …
resected stages I to III LUAD from April 8, 2010, to December 31, 2010. Tumor EGFR …